Global health and global governance of emerging biomedical technologies.


Journal

Journal of medical ethics
ISSN: 1473-4257
Titre abrégé: J Med Ethics
Pays: England
ID NLM: 7513619

Informations de publication

Date de publication:
10 2023
Historique:
received: 28 09 2022
accepted: 27 01 2023
medline: 25 9 2023
pubmed: 8 2 2023
entrez: 7 2 2023
Statut: ppublish

Résumé

Global governance of emerging, disruptive biomedical technologies presents a multitude of ethical problems. The recent paper by Shozi

Identifiants

pubmed: 36750323
pii: jme-2022-108673
doi: 10.1136/jme-2022-108673
doi:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

719-720

Commentaires et corrections

Type : CommentOn

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: The author is a member of the External Advisory Board for the Center for Embryonic Cell and Gene Therapy at Oregon Health and Science University. The author is a pro bono member and does not receive an honorarium for their service.

Auteurs

Bryan Cwik (B)

Philosophy, Portland State University, Portland, Oregon, USA bcwik@pdx.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH